Exagen

Exagen

XGN· Services· Fiscal year ends in December

CEO pay in FY2025Stock +48.3% in FY2025

John Aballi is the CEO of Exagen and was paid $1.4M in FY2025 (Dec), up 18%.

Pay$100 in the stock at the end of FY21 → $52
CEO pay is from each Exagen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives2

See all
  1. 1John AballiFY2025
  2. 2Jeffrey BlackFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Exagen paid its 2 named executives $2.1M in total in FY2025 (Dec). CEO John Aballi was paid $1.4M of that.

Name
John AballiPresident, Chief Executive Officer, Director and former Interim Chief Financial Officer
Jeffrey BlackChief Financial Officer and Corporate Secretary

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Exagen. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board4

See all
  • Bruce C. Robertson, Ph.D.Director · 6 yr on the boardIndependentCompensation, Nominating—Paid as an executive
  • Frank StokesDirector · 4 yr on the boardIndependentAudit (Chair), Nominating—Paid as an executive
  • Paul KimDirector · 2 yr on the boardIndependentAudit, Compensation—Paid as an executive
  • Scott D. Kahn, Ph.D.Director · 1 yr on the boardIndependentCompensation, Nominating (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 27, 2026FY2025
Annual report10-KMar 10, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 11, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 18, 2024FY2023